Can Sitagliptin delay the progression of prediabetes to full-blown diabetes, and what evidence supports its preventive role in high-risk populations?
Share
Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
Sitagliptin may slow prediabetes progression by improving β-cell function and glycemic control. A study by DPP Research showed its potential in high-risk groups.
Further studies are needed, but evidence suggests Sitagliptin could delay the onset of diabetes in prediabetic individuals by enhancing insulin sensitivity and secretion.